AbbVie to Present at the Bank of America Securities Healthcare Conference
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced its participation in the upcoming Bank of America Securities Healthcare Conference scheduled for Wednesday, May 14, 2025. The company's management will engage in a fireside chat session at 12:00 p.m. Central time. Investors and interested parties can access the live audio webcast through AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the presentation will be made available on the same day for those unable to attend the live session.
Positive
- None.
Negative
- None.
News Market Reaction – ABBV
In the trading session that priced this news, ABBV declined 4.55%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert | Investors: Liz Shea |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-302445308.html
SOURCE AbbVie
